CAR-T Cells in the Treatment of Ovarian Cancer: A Promising Cell Therapy

Ovarian cancer (OC) is among the most common gynecologic malignancies with a poor prognosis and a high mortality rate. Most patients are diagnosed at an advanced stage (stage III or IV), with 5-year survival rates ranging from 25% to 47% worldwide. Surgical resection and first-line chemotherapy are...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xi-Wen, Wu, Yi-Shi, Xu, Tian-Min, Cui, Man-Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046142/
https://www.ncbi.nlm.nih.gov/pubmed/36979400
http://dx.doi.org/10.3390/biom13030465

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046142/
https://www.ncbi.nlm.nih.gov/pubmed/36979400
http://dx.doi.org/10.3390/biom13030465

Ejemplares similares